Preferred Name |
vedolizumab |
|
Synonyms |
MLN-02 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C543529 |
|
altLabel |
MLN-02 MLN02 MLN-0002 Entyvio MLN0002 |
|
cui |
C2607726 C3715224 C2742797 |
|
HM |
D061067 |
|
Inverse of RB |
9RV78Q2002 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20090915 |
|
MeSH Frequency |
872 |
|
MMR |
20191101 |
|
notation |
C543529 |
|
PA |
D005765 |
|
prefLabel |
vedolizumab |
|
SC |
1 |
|
Scope Statement |
a humanized monoclonal antibody that targets the 4beta7 integrin exclusively, and modulates inflammation in the gastrointestinal tract |
|
SRC |
J Pharmacol Exp Ther. 2009 Sep;330(3):864-75 |
|
TERMUI |
T000966353 T000966355 T000886792 T000966354 T757782 T734368 |
|
TH |
NLM (2009) NLM (2020) NLM (2015) USAN (19XX) INN (19XX) |
|
tui |
T116 T129 T121 |
Create mapping